Literature DB >> 22472104

[Sickle-cell retinopathy: Retrospective study of 730 patients followed in a referral center].

N Leveziel1, F Lalloum, S Bastuji-Garin, M Binaghi, D Bachir, F Galacteros, E Souied.   

Abstract

INTRODUCTION: Sickle-cell disease is the most common genetic disease in the world, frequently complicated by potentially blinding retinal complications. The prevalence of sickle-cell retinopathy in patients followed in a referral center is presented in this study. PATIENTS AND METHODS: The prevalence of proliferative sickle-cell retinopathy by Goldberg classification was determined via a retrospective study of primarily adult SS and SC sickle-cell disease patients and AS sickle trait patients followed in a single referral center for a mean period of 13 years. All patients underwent slit lamp examination and complete fundus examination.
RESULTS: Seven hundred and thirty patients (mean age 32.5±10 years), consisting of 492 SS patients (67.4%), 229 SC patients (31.4%) and nine AS patients (1.2%), were included in the study. 54.6% of SC patients and 18.1% of SS patients had grade 3 to 5 proliferative sickle-cell retinopathy. The prevalence of severe forms of sickle-cell retinopathy was higher among SS men than among SS women (21.7% versus 15.5% ; P<0.05).
CONCLUSION: The high prevalence of sickle-cell retinopathy and the potentially severe complications associated with this disease justify screening and therapeutic management by a multidisciplinary team in the setting of a referral center.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22472104     DOI: 10.1016/j.jfo.2011.10.007

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  6 in total

Review 1.  Neuroimaging of ocular involvement in patients with sickle cell disease and review of the literature.

Authors:  José Fernando Vallejo Diaz; Rafael Glikstein; Marlise Peruzzo Dos Santos; Carlos Torres
Journal:  Neuroradiol J       Date:  2017-01-03

Review 2.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

3.  [Interests of the examination of the fundus in general practice: review of 438 cases].

Authors:  Jean Wenceslas Diallo; Nonfounikoun Méda; Somnoma Jean Baptiste Tougouma; Ahgbatouhabéba Ahnoux-Zabsonré; Rosane Yé; Pierre Djiguimdé; Jérôme Sanou; Paté Sankara; Gertrude Méda; Mariam Dolo
Journal:  Pan Afr Med J       Date:  2015-04-14

4.  Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report.

Authors:  Panagiotis G Mitropoulos; Irini P Chatziralli; Efstratios A Parikakis; Vasileios G Peponis; Georgios A Amariotakis; Marilita M Moschos
Journal:  Case Rep Ophthalmol Med       Date:  2014-11-23

Review 5.  Sickle cell retinopathy: improving care with a multidisciplinary approach.

Authors:  Farid Menaa; Barkat Ali Khan; Bushra Uzair; Abder Menaa
Journal:  J Multidiscip Healthc       Date:  2017-08-30

6.  Comparison of Ultra-Wide Field Photography to Ultra-Wide Field Angiography for the Staging of Sickle Cell Retinopathy.

Authors:  Héloise Torres-Villaros; Franck Fajnkuchen; Fatima Amari; Lucie Janicot; Audrey Giocanti-Aurégan
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.